Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis: comment on the article by Hetland et al Reply

被引:0
|
作者
Hetland, Merete Lund [1 ,2 ,3 ,4 ]
Linde, Louise [1 ,2 ,3 ,4 ]
Christensen, Ib Jarle [5 ]
Dreyer, Lene [5 ]
Tarp, Ulrik [6 ]
Hansen, Annette [7 ,8 ]
Hansen, Ib Tonder [9 ]
Kollerup, Gina [10 ]
Lindegaard, Hanne M. [11 ]
Poulsen, Uta Engling [12 ]
Schlemmer, Annette [13 ]
Jensen, Dorte Vendelbo [14 ]
Jensen, Signe [8 ]
Hostenkamp, Gisela [15 ]
Ostergaard, Mikkel [3 ,4 ,8 ]
机构
[1] DANBIO Registry, Hvidovre, Denmark
[2] DANBIO Registry, Glostrup, Denmark
[3] Copenhagen Univ Hosp, Hvidovre, Denmark
[4] Copenhagen Univ Hosp, Glostrup, Denmark
[5] Rigshosp, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark
[6] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
[7] DANBIO Registry, Gentofte, Denmark
[8] Copenhagen Univ Hosp, Gentofte, Denmark
[9] Viborg Hosp, Viborg, Denmark
[10] Copenhagen Univ Hosp, Frederiksberg, Denmark
[11] Odense Univ Hosp, DK-5000 Odense, Denmark
[12] Univ So Denmark, Grasten, Denmark
[13] Aarhus Univ Hosp, Aalborg, Denmark
[14] Horsholm Hosp, Horsholm, Denmark
[15] Inst Publ Hlth, Odense, Denmark
来源
ARTHRITIS AND RHEUMATISM | 2010年 / 62卷 / 09期
关键词
D O I
10.1002/art.27609
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2826 / 2828
页数:5
相关论文
共 50 条
  • [41] Association of Fcγ receptor IIIA polymorphism with rheumatoid arthritis:: Comment on the article by Morgan et al -: Reply
    Morgan, AW
    Griffiths, B
    Barrett, JH
    Markham, AF
    Emery, P
    Isaacs, JD
    ARTHRITIS AND RHEUMATISM, 2002, 46 (02): : 557 - 559
  • [42] HLA-DMA and DMB genes in rheumatoid arthritis: comment on the article by Pinet et al - Reply
    Pinet, V
    Eliaou, JF
    ARTHRITIS AND RHEUMATISM, 1998, 41 (05): : 947 - 948
  • [43] Is methotrexate as efficacious as etanercept in psoriatic arthritis patients? Comment on the article by Mease et al
    Kerschbaumer, Andreas
    Smolen, Josef S.
    Aletaha, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (07) : 1227 - 1229
  • [44] Importance of standardized methodology to comparisons between studies of rheumatoid arthritis and cardiovascular disease: comment on the article by Giles et al Reply
    Giles, Jon T.
    Szklo, Moyses
    Post, Wendy
    Gelber, Allan C.
    Bathon, Joan M.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : 3488 - 3488
  • [45] Reply to "Does Progranulin Account for the Opposite Effects of Etanercept and Infliximab/Adalimumab in Osteoarthritis?" by Wei et al.
    Olson, Steven A.
    Furman, Bridgette D.
    Kraus, Virginia B.
    Huebner, Janet L.
    Guilak, Farshid
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2016, 34 (01) : 15 - 16
  • [46] Drug-survival, effectiveness and safety of infliximab, adalimumab and etanercept in rheumatoid arthritis patients
    Flendrie, M.
    Creemers, M. C. W.
    Welsing, P. M. J.
    Van den Hoogen, F. H. J.
    Van Riel, P. L. C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 191 - 191
  • [47] Comparison of Dose Escalation and Co-therapy Intensification between Patients with Rheumatoid Arthritis Initiating Biologic Treatment with Etanercept, Adalimumab and Infliximab
    Thorne, Carter
    Boire, Gilles
    Chow, Andrew
    Garces, Kirsten
    Poulin-Costello, Melanie
    Walker, Valery
    Haraoui, Boulos
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1171 - 1171
  • [48] Cost of Etanercept, Adalimumab, and Infliximab in Patients with Rheumatoid Arthritis with Employer Provided Health Insurance
    Bonafede, Machaon
    Watson, Crystal
    Joseph, George
    Princic, Nicole
    Harrison, David J.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S778 - S778
  • [49] Comparison of Dose Escalation and Co-Therapy Intensification Between Patients with Rheumatoid Arthritis Initiating Biologic Treatment with Etanercept, Adalimumab and Infliximab
    Thorne, J. Carter
    Boire, Gilles
    Chow, Andrew
    Garces, Kirsten
    Liu, Fang
    Poulin-Costello, Melanie
    Walker, Valery
    Haraoui, Boulos
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [50] Studies of preclinical rheumatoid arthritis synovial histology-a comparison of animal models: comment on the article by de Hair et al Reply
    de Hair, M. J. H.
    van de Sande, M. G. H.
    Ramwadhdoebe, T. H.
    van der Leij, C.
    Maas, M.
    Hansson, M.
    Klareskog, L.
    Landewe, R.
    Serre, G.
    van Schaardenburg, D.
    Gerlag, D. M.
    van Baarsen, L. G. M.
    Tak, P. P.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (06) : 1683 - 1684